YHLO_Publications

YHLO published a high-quality article in the field of infection

Time Posted : 2023-11-30

YHLO assisted in the SARS-CoV-2 serosurveillance research in Madurai, South India

Time Posted : 2021-08-20

YHLO contributes to SARS-CoV-2-specific immune response research in COVID-19 convalescent individuals

Time Posted : 2021-08-19

YHLO Contributes to Lancet SARS-CoV-2 NAb Research

Time Posted : 2021-08-05

The mixed-and-match vaccine against Covid-19 tested a stronger immune response than two doses of AstraZeneca vaccine.

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +